FULGENT GENETICS, INC. (FLGT)
Fulgent Presents Updated FID-007 Data at ASCO 2026
Fulgent Presents Updated FID-007 Data at ASCO 2026
The Coca-Cola Company Exploring Potential Public Listing in India for Hindustan Coca-Cola Holdings Pvt. Ltd., Parent Company of its Largest Bottler in India
Results of institutional tender
U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged
Clinical trial NCT06619860 updates: 1. completion date: 2026-05-30 → 2027-04-22 2. primary completion date: 2026-04-30 → 2027-03-25
Clinical trial NCT07325461 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07555483 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-21 → 2026-05-05 3. completion date: 2026-09-29 → 2027-09-30 4. primary completion date: 2026-09-29 → 2027-09-30
Clinical trial NCT07459751: status: ENROLLING_BY_INVITATION → RECRUITING.
Clinical trial NCT06052631: start date: 2026-06-03 → 2026-06-04.
Clinical trial NCT04287647 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-06-06 → 2026-05-27 3. primary completion date: 2026-06-06 → 2026-05-27 4. enrollment: 36 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL